These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33937083)

  • 21. Corrigendum: Prognostic implication and immunotherapy response prediction of a ubiquitination-related gene signature in breast cancer.
    Guo Y; Chen Q; Zhang Y; Cheng X; Cen K; Dai Y; Mai Y; Hong K
    Front Genet; 2023; 14():1217912. PubMed ID: 37292143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a novel immune-related genes prognostic signature for osteosarcoma.
    Wu ZL; Deng YJ; Zhang GZ; Ren EH; Yuan WH; Xie QQ
    Sci Rep; 2020 Oct; 10(1):18402. PubMed ID: 33110201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corrigendum: EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways.
    Pan H; Pan J; Song S; Ji L; Lv H; Yang Z
    Front Oncol; 2021; 11():670041. PubMed ID: 33898326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients.
    Li LQ; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Khader MA; Jia-Wen ; Tao-Liu ; Li JZ
    Aging (Albany NY); 2020 Nov; 12(22):22906-22926. PubMed ID: 33203792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma.
    Hu X; Bao M; Huang J; Zhou L; Zheng S
    Front Oncol; 2020; 10():617539. PubMed ID: 33330112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corrigendum: Polymeric immunoglobulin receptor suppresses colorectal cancer through the AKT-FOXO3/4 axis by downregulating LAMB3 expression.
    Zhang D; Huang H; Zheng T; Zhang L; Cui B; Liu Y; Tan S; Zhao L; Tian T; Gao L; Fu Q; Cheng Z; Zhao Y
    Front Oncol; 2022; 12():1012871. PubMed ID: 36072792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corrigendum: Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective Study.
    Del Fiore P; Rastrelli M; Dall'Olmo L; Cavallin F; Cappellesso R; Vecchiato A; Buja A; Spina R; Parisi A; Mazzarotto R; Ferrazzi B; Grego A; Rotondi A; Benna C; Tropea S; Russano F; Filoni A; Bassetto F; Dei Tos AP; Alaibac M; Rossi CR; Pigozzo J; Chiarion Sileni V; Mocellin S
    Front Oncol; 2021; 11():686051. PubMed ID: 33937089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corrigendum: Identification of Immune-Related Prognostic Genes and LncRNAs Biomarkers Associated With Osteosarcoma Microenvironment.
    Zhang T; Nie Y; Xia H; Zhang Y; Cai K; Chen X; Li H; Wang J
    Front Oncol; 2020; 10():620320. PubMed ID: 33330113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corrigendum: Sperm Protein Antigen 17 Expression Correlates With Lymph Node Metastasis and Worse Overall Survival in Patients With Breast Cancer.
    Zhou YT; Qiu JJ; Wang Y; Liu PC; Lv Q; Du ZG
    Front Oncol; 2020; 10():1003. PubMed ID: 32670882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corrigendum: Construction and Validation of a Lung Cancer Risk Prediction Model for Non-Smokers in China.
    Guo LW; Lyu ZY; Meng QC; Zheng LY; Chen Q; Liu Y; Xu HF; Kang RH; Zhang LY; Cao XQ; Liu SZ; Sun XB; Zhang JG; Zhang SK
    Front Oncol; 2022; 12():871848. PubMed ID: 35311146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and Validation of a Prognostic Gene Signature for Diffuse Large B-Cell Lymphoma Based on Tumor Microenvironment-Related Genes.
    Pan T; He Y; Chen H; Pei J; Li Y; Zeng R; Xia J; Zuo Y; Qin L; Chen S; Xiao L; Zhou H
    Front Oncol; 2021; 11():614211. PubMed ID: 33692952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corrigendum: Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group.
    Racanelli D; Brenca M; Baldazzi D; Goeman F; Casini B; De Angelis B; Guercio M; Milano GM; Tamborini E; Busico A; Dagrada G; Garofalo C; Caruso C; Brunello A; Pignochino Y; Berrino E; Grignani G; Scotlandi K; Parra A; Hattinger CM; Ibrahim T; Mercatali L; De Vita A; Carriero MV; Pallocca M; Loria R; Covello R; Sbaraglia M; Dei Tos AP; Falcioni R; Maestro R
    Front Oncol; 2020; 10():944. PubMed ID: 32656080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corrigendum: Oncolytic Adenovirus-A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC.
    Abudoureyimu M; Lai Y; Tian C; Wang T; Wang R; Chu X
    Front Oncol; 2020; 10():701. PubMed ID: 32432043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corrigendum: A genome-wide investigation of effects of aberrant DNA methylation on the usage of alternative promoters in hepatocellular carcinoma.
    Dong Y; Liu X; Jiang B; Wei S; Xiang B; Liao R; Wang Q; He X
    Front Oncol; 2023; 13():1253552. PubMed ID: 37719011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corrigendum: Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study.
    Yin X; Chen L; Fan F; Yan H; Zhang Y; Huang Z; Sun C; Hu Y
    Front Oncol; 2021; 11():657016. PubMed ID: 33680976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Four-Pseudogene Classifier Identified by Machine Learning Serves as a Novel Prognostic Marker for Survival of Osteosarcoma.
    Liu F; Xing L; Zhang X; Zhang X
    Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corrigendum: NUSAP1 Promotes Gastric Cancer Tumorigenesis and Progression by Stabilizing the YAP1 Protein.
    Guo H; Zou J; Zhou L; Zhong M; He Y; Huang S; Chen J; Li J; Xiong J; Fang Z; Xiang X
    Front Oncol; 2021; 11():666560. PubMed ID: 33834001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma.
    Zhang K; Liu H; Yu M; Zhao H; Yang N; Bi X; Sun L; Lin R; Lü G
    Front Oncol; 2021; 11():785394. PubMed ID: 34722323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corrigendum: Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis.
    Altaf R; Ilyas U; Ma A; Shi M
    Front Oncol; 2024; 14():1377858. PubMed ID: 38651145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene signatures with predictive and prognostic survival values in human osteosarcoma.
    Qiu Z; Du X; Chen K; Dai Y; Wang S; Xiao J; Li G
    PeerJ; 2021; 9():e10633. PubMed ID: 33520450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.